What's new in DyslipidemiaLast update of the site: Tuesday, 21 January 2020

Yee‐Ming Cheung et al. | Internal Medicine Journal 2019; 49(12):...
Diabetes confers an independent risk to cardiovascular disease (CVD) but also shares many common comorbidities...
Khan, Safi U. et al. | The American Journal of Cardiology 2019;...
The impact of body mass index (BMI) on cardiovascular outcomes among patients receiving intensive low-density...
Dylan M. Williams PhD et al. | Annals of Neurology 2020; 87(1): 30-9...
There are no preventive or disease‐modifying treatments for Alzheimer disease (AD). Expanding the...
Alkhalil et al. | Atherosclerosis 2019; 293(-): 75-8
The recent reported analysis from the ODYSSEY OUTCOMES trial showed that patients with previous coronary...
Yu-Ching Chou et al. | Journal of Investigative Medicine 2019;...
The statins are currently the most commonly prescribed lipid-lowering agents that are widely used in...
Masuda, Daisaku et al. | Atherosclerosis 2019; 292(-): 163-70...
We aimed to investigate blood lipid and lipoprotein profiles in patients with dyslipidemia receiving...
Feiyu Hu et al. | Pharmacoepidemiology and Drug Safety...
Cardiovascular disease (CVD) is a globally leading cause of death, accounting for 17.9 million deaths...
Brunner, Fabian J et al. | The Lancet 2019; 394(10215): 2173-83...
The relevance of blood lipid concentrations to long-term incidence of cardiovascular disease and the...
Faubion, Stephanie S.MD et al. | Menopause 2019; 26(12): 1425-35
Statins refer to a class of drugs originally approved by the US Food and Drug Administration (FDA) for...
Ying Jie et al. | European Journal of Clinical Nutrition...
According to data from the Word Health Organization (WHO), cardiovascular diseases (CVD) remain the leading...

Bibliographical searchFocus and target to your research of scientific data

Research by journal
419 articles currently available
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesThe 5 most read articles

Yee‐Ming Cheung et al. | Internal Medicine Journal 2019; 49(12):...
Diabetes confers an independent risk to cardiovascular disease (CVD) but also shares many common comorbidities such as hypertension and dyslipidaemia. CVD remains the commonest cause of death in individuals...
Masuda, Daisaku et al. | Atherosclerosis 2019; 292(-): 163-70...
We aimed to investigate blood lipid and lipoprotein profiles in patients with dyslipidemia receiving hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) after 8 weeks of omega-3 fatty acid...
Alkhalil et al. | Atherosclerosis 2019; 293(-): 75-8
The recent reported analysis from the ODYSSEY OUTCOMES trial showed that patients with previous coronary bypass graft surgery (CABG) conferred enhanced clinical benefits in response to intensive low-density...
Brunner, Fabian J et al. | The Lancet 2019; 394(10215): 2173-83...
The relevance of blood lipid concentrations to long-term incidence of cardiovascular disease and the relevance of lipid-lowering therapy for cardiovascular disease outcomes is unclear. We investigated...
Dylan M. Williams PhD et al. | Annals of Neurology 2020; 87(1): 30-9...
There are no preventive or disease‐modifying treatments for Alzheimer disease (AD). Expanding the indications of drugs of proven efficacy into other indications might be an effective strategy to...